Selected research
Industry Research
Preclinical Testing Service Industry Research Report 2026
Market perspective
The global Preclinical Testing Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Preclinical Testing Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Preclinical Testing Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Preclinical Testing Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Preclinical Testing Service include Charles River Laboratories, Eurofins Scientific, NorthEast BioAnalytical Laboratories LLC., GCMI, Altogen Labs, American Preclinical Services, ABL, VIMTA and Medicilon, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Preclinical Testing Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Preclinical Testing Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Preclinical Testing Service Market by Company
Charles River Laboratories
Eurofins Scientific
NorthEast BioAnalytical Laboratories LLC.
GCMI
Altogen Labs
American Preclinical Services
ABL
VIMTA
Medicilon
ALTASCIENCES
Labcorp
ARL Bio Pharma
Absorption Systems
WuXi AppTec
IDEXX Laboratories, Inc.
LEVEL Biotechnology
Viroclinics-DDL
Albany Molecular Research Inc.
Preclinical Testing Service Segment by Type
Analytical Method Development Services
Drug Testing Services
Drug Contract Biological Testing Services
Drug Pharmacodynamic Testing Services
Preclinical Toxicology Testing Services
Other
Preclinical Testing Service Segment by Application
Laboratory
Medicine
Other
Preclinical Testing Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Preclinical Testing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Preclinical Testing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Preclinical Testing Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Preclinical Testing Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Analytical Method Development Services
- Drug Testing Services
- Drug Contract Biological Testing Services
- Drug Pharmacodynamic Testing Services
- Preclinical Toxicology Testing Services
- Other
Applications
- Laboratory
- Medicine
- Other
Companies covered
- Charles River Laboratories
- Eurofins Scientific
- NorthEast BioAnalytical Laboratories LLC.
- GCMI
- Altogen Labs
- American Preclinical Services
- ABL
- VIMTA
- Medicilon
- ALTASCIENCES
- Labcorp
- ARL Bio Pharma
- Absorption Systems
- WuXi AppTec
- IDEXX Laboratories, Inc.
- LEVEL Biotechnology
- Viroclinics-DDL
- Albany Molecular Research Inc.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Preclinical Testing Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Analytical Method Development Services
- 2.2.3 Drug Testing Services
- 2.2.4 Drug Contract Biological Testing Services
- 2.2.5 Drug Pharmacodynamic Testing Services
- 2.2.6 Preclinical Toxicology Testing Services
- 2.2.7 Other
- 2.3 Preclinical Testing Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Laboratory
- 2.3.3 Medicine
- 2.3.4 Other
- 2.4 Assumptions and Limitations
3 Preclinical Testing Service Breakdown Data by Type
- 3.1 Global Preclinical Testing Service Historic Market Size by Type (2021-2026)
- 3.2 Global Preclinical Testing Service Forecasted Market Size by Type (2027-2032)
4 Preclinical Testing Service Breakdown Data by Application
- 4.1 Global Preclinical Testing Service Historic Market Size by Application (2021-2026)
- 4.2 Global Preclinical Testing Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Preclinical Testing Service Market Perspective (2021-2032)
- 5.2 Global Preclinical Testing Service Growth Trends by Region
- 5.2.1 Global Preclinical Testing Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Preclinical Testing Service Historic Market Size by Region (2021-2026)
- 5.2.3 Preclinical Testing Service Forecasted Market Size by Region (2027-2032)
- 5.3 Preclinical Testing Service Market Dynamics
- 5.3.1 Preclinical Testing Service Industry Trends
- 5.3.2 Preclinical Testing Service Market Drivers
- 5.3.3 Preclinical Testing Service Market Challenges
- 5.3.4 Preclinical Testing Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Preclinical Testing Service Players by Revenue
- 6.1.1 Global Top Preclinical Testing Service Players by Revenue (2021-2026)
- 6.1.2 Global Preclinical Testing Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Preclinical Testing Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Preclinical Testing Service Head Office and Area Served
- 6.4 Global Preclinical Testing Service Players, Product Type & Application
- 6.5 Global Preclinical Testing Service Manufacturers Established Date
- 6.6 Global Preclinical Testing Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Preclinical Testing Service Market Size (2021-2032)
- 7.2 North America Preclinical Testing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Preclinical Testing Service Market Size by Country (2021-2026)
- 7.4 North America Preclinical Testing Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Preclinical Testing Service Market Size (2021-2032)
- 8.2 Europe Preclinical Testing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Preclinical Testing Service Market Size by Country (2021-2026)
- 8.4 Europe Preclinical Testing Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Preclinical Testing Service Market Size (2021-2032)
- 9.2 Asia-Pacific Preclinical Testing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Preclinical Testing Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Preclinical Testing Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Preclinical Testing Service Market Size (2021-2032)
- 10.2 South America Preclinical Testing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Preclinical Testing Service Market Size by Country (2021-2026)
- 10.4 South America Preclinical Testing Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Preclinical Testing Service Market Size (2021-2032)
- 11.2 Middle East & Africa Preclinical Testing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Preclinical Testing Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Preclinical Testing Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Charles River Laboratories
- 12.1.1 Charles River Laboratories Company Information
- 12.1.2 Charles River Laboratories Business Overview
- 12.1.3 Charles River Laboratories Revenue in Preclinical Testing Service Business (2021-2026)
- 12.1.4 Charles River Laboratories Preclinical Testing Service Product Portfolio
- 12.1.5 Charles River Laboratories Recent Developments
- 12.2 Eurofins Scientific
- 12.2.1 Eurofins Scientific Company Information
- 12.2.2 Eurofins Scientific Business Overview
- 12.2.3 Eurofins Scientific Revenue in Preclinical Testing Service Business (2021-2026)
- 12.2.4 Eurofins Scientific Preclinical Testing Service Product Portfolio
- 12.2.5 Eurofins Scientific Recent Developments
- 12.3 NorthEast BioAnalytical Laboratories LLC.
- 12.3.1 NorthEast BioAnalytical Laboratories LLC. Company Information
- 12.3.2 NorthEast BioAnalytical Laboratories LLC. Business Overview
- 12.3.3 NorthEast BioAnalytical Laboratories LLC. Revenue in Preclinical Testing Service Business (2021-2026)
- 12.3.4 NorthEast BioAnalytical Laboratories LLC. Preclinical Testing Service Product Portfolio
- 12.3.5 NorthEast BioAnalytical Laboratories LLC. Recent Developments
- 12.4 GCMI
- 12.4.1 GCMI Company Information
- 12.4.2 GCMI Business Overview
- 12.4.3 GCMI Revenue in Preclinical Testing Service Business (2021-2026)
- 12.4.4 GCMI Preclinical Testing Service Product Portfolio
- 12.4.5 GCMI Recent Developments
- 12.5 Altogen Labs
- 12.5.1 Altogen Labs Company Information
- 12.5.2 Altogen Labs Business Overview
- 12.5.3 Altogen Labs Revenue in Preclinical Testing Service Business (2021-2026)
- 12.5.4 Altogen Labs Preclinical Testing Service Product Portfolio
- 12.5.5 Altogen Labs Recent Developments
- 12.6 American Preclinical Services
- 12.6.1 American Preclinical Services Company Information
- 12.6.2 American Preclinical Services Business Overview
- 12.6.3 American Preclinical Services Revenue in Preclinical Testing Service Business (2021-2026)
- 12.6.4 American Preclinical Services Preclinical Testing Service Product Portfolio
- 12.6.5 American Preclinical Services Recent Developments
- 12.7 ABL
- 12.7.1 ABL Company Information
- 12.7.2 ABL Business Overview
- 12.7.3 ABL Revenue in Preclinical Testing Service Business (2021-2026)
- 12.7.4 ABL Preclinical Testing Service Product Portfolio
- 12.7.5 ABL Recent Developments
- 12.8 VIMTA
- 12.8.1 VIMTA Company Information
- 12.8.2 VIMTA Business Overview
- 12.8.3 VIMTA Revenue in Preclinical Testing Service Business (2021-2026)
- 12.8.4 VIMTA Preclinical Testing Service Product Portfolio
- 12.8.5 VIMTA Recent Developments
- 12.9 Medicilon
- 12.9.1 Medicilon Company Information
- 12.9.2 Medicilon Business Overview
- 12.9.3 Medicilon Revenue in Preclinical Testing Service Business (2021-2026)
- 12.9.4 Medicilon Preclinical Testing Service Product Portfolio
- 12.9.5 Medicilon Recent Developments
- 12.10 ALTASCIENCES
- 12.10.1 ALTASCIENCES Company Information
- 12.10.2 ALTASCIENCES Business Overview
- 12.10.3 ALTASCIENCES Revenue in Preclinical Testing Service Business (2021-2026)
- 12.10.4 ALTASCIENCES Preclinical Testing Service Product Portfolio
- 12.10.5 ALTASCIENCES Recent Developments
- 12.11 Labcorp
- 12.11.1 Labcorp Company Information
- 12.11.2 Labcorp Business Overview
- 12.11.3 Labcorp Revenue in Preclinical Testing Service Business (2021-2026)
- 12.11.4 Labcorp Preclinical Testing Service Product Portfolio
- 12.11.5 Labcorp Recent Developments
- 12.12 ARL Bio Pharma
- 12.12.1 ARL Bio Pharma Company Information
- 12.12.2 ARL Bio Pharma Business Overview
- 12.12.3 ARL Bio Pharma Revenue in Preclinical Testing Service Business (2021-2026)
- 12.12.4 ARL Bio Pharma Preclinical Testing Service Product Portfolio
- 12.12.5 ARL Bio Pharma Recent Developments
- 12.13 Absorption Systems
- 12.13.1 Absorption Systems Company Information
- 12.13.2 Absorption Systems Business Overview
- 12.13.3 Absorption Systems Revenue in Preclinical Testing Service Business (2021-2026)
- 12.13.4 Absorption Systems Preclinical Testing Service Product Portfolio
- 12.13.5 Absorption Systems Recent Developments
- 12.14 WuXi AppTec
- 12.14.1 WuXi AppTec Company Information
- 12.14.2 WuXi AppTec Business Overview
- 12.14.3 WuXi AppTec Revenue in Preclinical Testing Service Business (2021-2026)
- 12.14.4 WuXi AppTec Preclinical Testing Service Product Portfolio
- 12.14.5 WuXi AppTec Recent Developments
- 12.15 IDEXX Laboratories, Inc.
- 12.15.1 IDEXX Laboratories, Inc. Company Information
- 12.15.2 IDEXX Laboratories, Inc. Business Overview
- 12.15.3 IDEXX Laboratories, Inc. Revenue in Preclinical Testing Service Business (2021-2026)
- 12.15.4 IDEXX Laboratories, Inc. Preclinical Testing Service Product Portfolio
- 12.15.5 IDEXX Laboratories, Inc. Recent Developments
- 12.16 LEVEL Biotechnology
- 12.16.1 LEVEL Biotechnology Company Information
- 12.16.2 LEVEL Biotechnology Business Overview
- 12.16.3 LEVEL Biotechnology Revenue in Preclinical Testing Service Business (2021-2026)
- 12.16.4 LEVEL Biotechnology Preclinical Testing Service Product Portfolio
- 12.16.5 LEVEL Biotechnology Recent Developments
- 12.17 Viroclinics-DDL
- 12.17.1 Viroclinics-DDL Company Information
- 12.17.2 Viroclinics-DDL Business Overview
- 12.17.3 Viroclinics-DDL Revenue in Preclinical Testing Service Business (2021-2026)
- 12.17.4 Viroclinics-DDL Preclinical Testing Service Product Portfolio
- 12.17.5 Viroclinics-DDL Recent Developments
- 12.18 Albany Molecular Research Inc.
- 12.18.1 Albany Molecular Research Inc. Company Information
- 12.18.2 Albany Molecular Research Inc. Business Overview
- 12.18.3 Albany Molecular Research Inc. Revenue in Preclinical Testing Service Business (2021-2026)
- 12.18.4 Albany Molecular Research Inc. Preclinical Testing Service Product Portfolio
- 12.18.5 Albany Molecular Research Inc. Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst